Medical applications of microarray technologies: a regulatory science perspective.
about
Database development in toxicogenomics: issues and efforts.OligoDesign: optimal design of LNA (locked nucleic acid) oligonucleotide capture probes for gene expression profilingArrayD: a general purpose software for microarray designGene expression levels assessed by oligonucleotide microarray analysis and quantitative real-time RT-PCR -- how well do they correlate?Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney DiseaseBIOPHYSICAL PROPERTIES OF NUCLEIC ACIDS AT SURFACES RELEVANT TO MICROARRAY PERFORMANCE.Functional genomics studied by proteomics.Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.Evaluating methods for classifying expression data.Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential.Effect of various normalization methods on Applied Biosystems expression array system data.Proteomics in pathology research.Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarraysThe impact of sample imbalance on identifying differentially expressed genes.Elevated expression of protein regulator of cytokinesis 1, involved in the growth of breast cancer cells.Exploring the use of internal and externalcontrols for assessing microarray technical performanceEmpirical establishment of oligonucleotide probe design criteriaUse of microarrays with different probe sizes for monitoring gene expression.Oncogenic role of NALP7 in testicular seminomas.Targeted therapies in cancer - challenges and chances offered by newly developed techniques for protein analysis in clinical tissues.Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis.Prediction of individual response to anticancer therapy: historical and future perspectivesMicroarray technology--an intellectual property retrospective.Gene expression profiling and its application in studies of haematological malignancy.Molecular Features of Triple Negative Breast Cancer: Microarray Evidence and Further Integrated Analysis.Molecular profiling approaches for identifying novel biomarkers.Proteomics in transfusion medicine.Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patientsFuture directions in cancer research: impact of the completion of the human genome.Development and use of biomarkers in oncology drug development.Some statistical and regulatory issues in the evaluation of genetic and genomic tests.A perspective on DNA microarrays in pathology research and practiceDevelopment and validation of DNA microarray for genotyping group A rotavirus VP4 (P[4], P[6], P[8], P[9], and P[14]) and VP7 (G1 to G6, G8 to G10, and G12) genes.Toxicogenomics and systems toxicology: aims and prospects.How molecular profiling could revolutionize drug discovery.Microarrays in veterinary diagnostics.Applications of emerging technologies in toxicology and safety assessment.Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.Optimal sampling of rat liver tissue for toxicogenomic studiesThe emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation.
P2860
Q24530174-9559C077-A794-45C4-88B7-8F1BB348DF38Q24575548-CDA7E953-3C87-4306-A826-D820BE4BE0EDQ24804830-5ADDE0FD-48AC-4CCC-8772-36BF5D1851E7Q24810251-CD5BF245-D592-45ED-9785-554078192189Q26740125-7EB4DC50-180B-47CA-8C60-602FB1BFC89FQ30415150-F3FD0240-53B7-4FFB-93AF-6552A207D362Q30765248-76F2FBCB-9D8D-46D6-8A94-CE517C28C924Q30939419-CBBEC622-E7C4-42EB-AB34-73CA8DAC0B3DQ30978092-F56C812E-BEF2-42D0-B5C1-72066B2C4B7BQ30994965-616B1512-F288-4EA0-AAF3-C63801901976Q31085877-D0621621-27C3-4479-8521-D4AB20006C88Q31105602-4C853D22-B733-4EFF-B3F2-34BD1D8E937AQ33237195-111533FC-7B8F-4533-9AC1-2D367C995146Q33268949-C2ADCF9D-98F9-4655-81A4-FFDF03996C35Q33269602-F6BBD160-0239-460B-B6C1-7C2BC7823541Q33781434-2C143DAF-95B7-403B-A10D-F7D61477994FQ33884644-8FA79B95-E307-461E-92EA-E504871419D5Q33996004-E889E239-5513-4504-83AC-790F8CE748CAQ34375909-5871F739-1881-4833-BA3C-D8DDF558CE18Q34422523-5F40934D-5C8E-4B78-81EE-E8AB5BBA13C0Q34621899-C50C53C8-B80E-464B-8E01-FEEB0ABE2058Q35024682-0E6A27DD-BE09-4FBF-90E4-C960BD4987ACQ35207557-4E1A6599-A6DB-4A53-886F-6CD1FD384D24Q35661018-862B2FCE-3613-4FCE-B295-4E65D4B48ED3Q35671951-FC2A01E9-F82A-4E97-980D-4C17B4FC8A65Q35684838-9549D282-72CB-4DCF-9F1E-47A289681B8CQ35714177-04201BF7-F08E-40D1-BF92-073F2AA4E553Q35799435-4724521A-90AD-4EC5-86F0-8FFC564C5140Q35812467-04C8457F-D4CA-4BC8-83B1-189745021228Q35812532-832C1CE6-B0D0-4C11-9936-E6088C0384D7Q35910906-742A6066-2CB0-4E55-98D5-AD4D8262D87CQ35916012-1EBA0FEC-C81E-449F-B245-C1193BD7158CQ35947518-4934B94F-5214-49A0-8CEF-CF8AAE9121D2Q35968452-3BB3542F-17B1-479B-8C77-1FDCD5B175DDQ36079232-215660E0-EC71-4360-9D83-FD5AF4F6F7B3Q36177378-9926AD03-FF6C-4C45-8FBF-839FA5FCA2A2Q36205643-CD21E944-5704-46D2-91D3-283B52357EC4Q36205652-D8F0710E-AA2C-41EA-A2EF-E19A2C532882Q36253678-D10F3EBD-82DF-4D03-BD65-807FD9F2A07CQ36425978-B7CE16FB-9F5D-4E82-9205-346C476EA655
P2860
Medical applications of microarray technologies: a regulatory science perspective.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Medical applications of microarray technologies: a regulatory science perspective.
@ast
Medical applications of microarray technologies: a regulatory science perspective.
@en
type
label
Medical applications of microarray technologies: a regulatory science perspective.
@ast
Medical applications of microarray technologies: a regulatory science perspective.
@en
prefLabel
Medical applications of microarray technologies: a regulatory science perspective.
@ast
Medical applications of microarray technologies: a regulatory science perspective.
@en
P2093
P356
P1433
P1476
Medical applications of microarray technologies: a regulatory science perspective.
@en
P2093
David W Feigal
Emanuel F Petricoin
Frank D Sistare
Janet Woodcock
Joseph L Hackett
Kathryn C Zoon
Konstantin Chumakov
Lawrence J Lesko
Raj K Puri
Steven I Gutman
P2888
P304
P356
10.1038/NG1029
P407
P478
P577
2002-12-01T00:00:00Z
P5875
P6179
1039977644